MSD vs. TMO
MSD (Morgan Stanley Emerging Markets Debt Fund, Inc.) and TMO (Thermo Fisher Scientific Inc.) are both stocks. MSD operates in Asset Management (Financial Services), while TMO operates in Diagnostics & Research (Healthcare). Over the past 10 years, MSD returned 4.84%/yr vs 14.21%/yr for TMO. Their 0.20 correlation means their historical movements had little consistent relationship.
Performance
MSD vs. TMO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MSD achieves a 2.01% return, which is significantly higher than TMO's -0.69% return. Over the past 10 years, MSD has underperformed TMO with an annualized return of 4.84%, while TMO has yielded a comparatively higher 14.21% annualized return.
MSD
- 1D
- -0.41%
- 1M
- -0.55%
- 6M
- -1.72%
- YTD
- 2.01%
- 1Y
- 5.66%
- 3Y*
- 15.08%
- 5Y*
- 3.89%
- 10Y*
- 4.84%
- ALL TIME*
- 7.16%
TMO
- 1D
- -0.43%
- 1M
- 9.72%
- 6M
- -0.55%
- YTD
- -0.69%
- 1Y
- 24.48%
- 3Y*
- 2.03%
- 5Y*
- 1.52%
- 10Y*
- 14.21%
- ALL TIME*
- 12.29%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $462.06K | $515.29K | $664.52K | |
| $1.57B | $1.22B | $1.19B |
MSD vs. TMO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MSD Morgan Stanley Emerging Markets Debt Fund, Inc. | 2.01% | 5.58% | 24.92% | 19.14% | -22.10% | 2.20% | 0.73% | 24.38% | -12.31% | 16.33% |
TMO Thermo Fisher Scientific Inc. | -0.69% | 11.78% | -1.72% | -3.36% | -17.29% | 43.54% | 43.72% | 45.55% | 18.21% | 35.03% |
Correlation
The correlation between MSD and TMO is 0.20, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.20 |
Correlation (3Y) Balances recent behavior with more history. | 0.19 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.23 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.22 |
Correlation (All Time) Calculated using the full available price history since Oct 27, 1994 | 0.20 |
Fundamentals
MSD:
$146.47M
TMO:
$213.42B
MSD:
$1.85
TMO:
$18.62
MSD:
3.91
TMO:
30.84
MSD:
3.80
TMO:
4.64
MSD:
0.92
TMO:
4.04
MSD:
$38.58M
TMO:
$46.34B
MSD:
$35.05M
TMO:
$18.71B
MSD:
$30.02M
TMO:
$10.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MSD vs. TMO — Risk / Return Rank
MSD
TMO
MSD vs. TMO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Morgan Stanley Emerging Markets Debt Fund, Inc. (MSD) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MSD | TMO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.20 | ||
| Sortino ratioReturn per unit of downside risk | -0.51 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.16 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 0.54 | 0.74 | -0.21 |
| Martin ratioReturn relative to average drawdown | 1.48 | 1.46 | +0.02 |
Loading charts...
Drawdowns
MSD vs. TMO - Drawdown Comparison
The maximum MSD drawdown since its inception was -58.51%, smaller than the maximum TMO drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for MSD and TMO.
Loading charts...
Drawdown Indicators
| MSD | TMO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.51% | -71.16% | +12.65% |
Max Drawdown (1Y)Largest decline over 1 year | -10.59% | -31.38% | +20.79% |
Max Drawdown (3Y)Largest decline over 3 years | -12.84% | -37.28% | +24.44% |
Max Drawdown (5Y)Largest decline over 5 years | -33.89% | -40.95% | +7.06% |
Max Drawdown (10Y)Largest decline over 10 years | -37.50% | -40.95% | +3.45% |
Current DrawdownCurrent decline from peak | -4.94% | -12.79% | +7.85% |
Average DrawdownAverage peak-to-trough decline | -11.27% | -18.12% | +6.85% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.84% | 15.94% | -12.10% |
Volatility
MSD vs. TMO - Volatility Comparison
The current volatility for Morgan Stanley Emerging Markets Debt Fund, Inc. (MSD) is 2.45%, while Thermo Fisher Scientific Inc. (TMO) has a volatility of 10.24%. This indicates that MSD experiences smaller price fluctuations and is considered to be less risky than TMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MSD | TMO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 2.45% | 10.24% | -7.79% |
Volatility (6M)Calculated over the trailing 6-month period | 8.35% | 24.17% | -15.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 10.03% | 30.65% | -20.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.06% | 27.64% | -13.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 14.72% | 26.57% | -11.85% |
Dividends
MSD vs. TMO - Dividend Comparison
MSD's dividend yield for the trailing twelve months is around 8.43%, more than TMO's 0.31% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MSD Morgan Stanley Emerging Markets Debt Fund, Inc. | 8.43% | 9.88% | 11.88% | 10.90% | 7.34% | 4.99% | 4.67% | 5.37% | 6.56% | 5.81% | 6.87% | 7.03% |
TMO Thermo Fisher Scientific Inc. | 0.31% | 0.30% | 0.30% | 0.26% | 0.22% | 0.16% | 0.19% | 0.23% | 0.30% | 0.32% | 0.43% | 0.42% |
Financials
MSD vs. TMO - Financials Comparison
This section allows you to compare key financial metrics between Morgan Stanley Emerging Markets Debt Fund, Inc. and Thermo Fisher Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MSD and TMO have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TMO has higher volatility (10.24%) compared to MSD (2.45%). In terms of maximum drawdown, MSD dropped -58.51% vs TMO's -71.16%.
TMO currently has the higher Sharpe Ratio (0.76 vs 0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MSD and TMO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer